Abstract
Exacerbations of pulmonary symptoms in patients with cystic fibrosis must be recognised early and treated vigorously in order to maintain pulmonary function and relieve symptoms. The aetiology of these exacerbations is discussed, together with the options for treatment and the evidence to support treatment choices.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / therapeutic use*
-
Child
-
Cystic Fibrosis / complications*
-
Cystic Fibrosis / diagnostic imaging
-
Humans
-
Lung Diseases / diagnostic imaging
-
Lung Diseases / drug therapy*
-
Lung Diseases / microbiology
-
Pseudomonas Infections / diagnostic imaging
-
Pseudomonas Infections / drug therapy*
-
Pseudomonas aeruginosa
-
Tomography, X-Ray Computed
-
Treatment Outcome